Recent Events & Catalysts
ACADIA Pharmaceuticals Inc. (ACAD) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $39
Benzinga · 1d ago
Stoke: 'Buy' On Zorevunersen NDA SCN1A DS And STK-002 Advancement
SeekingAlpha · 6d ago
Oppenheimer Maintains Perform on ACADIA Pharmaceuticals, Raises Price Target to $25
Benzinga · 6d ago
RBC Capital Maintains Outperform on ACADIA Pharmaceuticals, Raises Price Target to $37
Benzinga · 6d ago
Citizens Maintains Market Outperform on ACADIA Pharmaceuticals, Raises Price Target to $36
Benzinga · 6d ago
ACADIA Pharmaceuticals Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 6d ago
ACADIA Pharmaceuticals Inc. (ACAD) Q2 2026 Earnings Call Transcript
SeekingAlpha · 7d ago
ACADIA Pharmaceuticals (NASDAQ:ACAD) Q2 Earnings Beat, Stock Rises on Raised Guidance
ChartMill · 7d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-04 · 8d ago · Material
Departure/appointment of directors or officers, Submission of matters to a vote of security holders, Financial statements and exhibits
Filed 2026-05-29 · 75d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.